{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T21:03:41Z","timestamp":1791147821955,"version":"4.1.0"},"reference-count":18,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2011,7,6]],"date-time":"2011-07-06T00:00:00Z","timestamp":1309910400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J of Inher Metab Disea"],"published-print":{"date-parts":[[2012,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Monitoring of therapeutic response in mucopolysaccharidosis (MPS) patients is problematic as most biomarkers are specific for either disease complications or specific organ system involvement. Recent studies have indicated that serum heparin\u2010cofactor II\u2010thrombin complex (HCII\u2010T) may serve as an important biomarker in the group of MPSs where dermatan sulphate is stored. This complex forms when blood coagulates in the presence of glycosaminoglycans (GAGs) where the ultimate amount of HCII\u2010T that forms reflects the concentration of circulating GAGs. We have studied serum HCII\u2010T levels in 9 MPS I and 11 MPS II treated patients and have compared values to studies of urinary GAGs. In severe MPS I patients treated with either transplantation or enzyme replacement therapy (ERT), serum HCII\u2010T levels never reach the range of normal despite normalization of uGAGs in some patients. Some attenuated MPS I patients have normalization of HCII\u2010T but require a protracted exposure time relative to the drop in urinary GAGs. Treated MPS II patients show a clear correlation of serum HCII\u2010T levels with the presence of antibodies to Idursulfase, with antibody positive patients showing an early drop in HCII\u2010T levels with eventual increases in levels often to levels above those seen at baseline. This is contrasted by a robust and persistent drop in uGAGs. Antibody negative MPS II patients show a drop in HCII\u2010T levels on treatment but levels never normalize despite normalization of uGAGs. This study highlights the utility and biologic relevance of serum HCII\u2010T levels in monitoring therapy in these disorders.<\/jats:p>","DOI":"10.1007\/s10545-011-9369-6","type":"journal-article","created":{"date-parts":[[2011,7,5]],"date-time":"2011-07-05T08:34:08Z","timestamp":1309854848000},"page":"355-362","source":"Crossref","is-referenced-by-count":19,"title":["Longitudinal observations of serum heparin cofactor II\u2010thrombin complex in treated Mucopolysaccharidosis I and II patients"],"prefix":"10.1002","volume":"35","author":[{"given":"Lorne Andrew","family":"Clarke","sequence":"first","affiliation":[{"name":"Department of Medical Genetics, The Child and Family Research Institute University of British Columbia 4500 Oak Street, RM C234 Vancouver BC V6H\u20103N1 Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harmony","family":"Hemmelgarn","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics, The Child and Family Research Institute University of British Columbia 4500 Oak Street, RM C234 Vancouver BC V6H\u20103N1 Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Colobong","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics, The Child and Family Research Institute University of British Columbia 4500 Oak Street, RM C234 Vancouver BC V6H\u20103N1 Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Thomas","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics, The Child and Family Research Institute University of British Columbia 4500 Oak Street, RM C234 Vancouver BC V6H\u20103N1 Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia","family":"Stockler","sequence":"additional","affiliation":[{"name":"Department of Pediatrics University of British Columbia Vancouver BC Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Casey","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics University of Calgary Calgary AB Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"Chan","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics University of Alberta Edmonton AB Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Fernoff","sequence":"additional","affiliation":[{"name":"Department of Human Genetics Emory University Atlanta GA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Mitchell","sequence":"additional","affiliation":[{"name":"Department of Pediatrics McGill University Montreal QC Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,7,6]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.GIM.0000153660.88672.3C"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1017\/S1462399408000550"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2007-3847"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1177\/000456329403100309"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2008.10.009"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1538-7836.2003.00305.x"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2009.10.175"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-010-9254-8"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0248-8663(06)80009-3"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.21888"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.gim.0000232477.37660.fb"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2006.09.001"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1097\/GIM.0b013e3181fea459"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-4658.2005.04880.x"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminhematol.2009.10.008"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2006.01.005"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2008.05.001"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2004.01.046"}],"container-title":["Journal of Inherited Metabolic Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1007\/s10545-011-9369-6","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1007\/s10545-011-9369-6","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1007\/s10545-011-9369-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T22:03:43Z","timestamp":1694815423000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1007\/s10545-011-9369-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7,6]]},"references-count":18,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["10.1007\/s10545-011-9369-6"],"URL":"https:\/\/doi.org\/10.1007\/s10545-011-9369-6","archive":["Portico"],"relation":{},"ISSN":["0141-8955","1573-2665"],"issn-type":[{"value":"0141-8955","type":"print"},{"value":"1573-2665","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,7,6]]}}}